medigraphic.com

2009, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2009; 47 (6)

The Alternative Medicine Used as Complementary in Patients Positive HIV

Herrera-Arellano A, Jaime-Delgado M, Herrera-Álvarez S, Oaxaca-Navarro J, Salazar-Martínez E

Language: Spanish
References: 45
Page: 651-602
PDF size: 53.76 Kb.


ABSTRACT

Objective: to evaluate the use of complementary alternative medicine (CAM) in patients infected with the human immunodeficiency virus (HIV), and to identify the type and factors associated to its use.
Methods: cross-sectional study made in HIV clinics of three majors institutions from Morelos State, Mexico; the sample was 293 subjects; a specific questionnaire looking for demographic information and CAM use was applied.
Results: The use of CAM was 73.4 %; 71 % informed to the physician of their use. 51 % of the patients reported using nutritional complements, 29.7 % herbal products and 19 % used physical agents like exercise, Chinese medicine, and therapy by contact. The 96.6 % of the users reported some perception of benefit with its use. The patients with low income, IMSS beneficiaries and on antirretroviral treatment are the greatest CAM users.
Conclusions: CAM use is a common practice among HIV (+) patients. The multivitamins and herbal products were the most used. The majority is prescribed by health personnel and the users showed some benefit. Other longitudinal studies are required to establish the CAM impact on the disease evolution and the quality of life of HIV (+) patients.


REFERENCES

  1. Duarte-Gómez MB. Western medicine and alternative medicines: can they be complementary? Conceptual reflections. Cad Saude Publica 2003; 19:635-643.

  2. National Center for Complementary and Alternative Medicine. What is CAM? An overview. Disponible en http://nccam.nih.gov/health/whatiscam/

  3. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.

  4. Palinkas LA, Kabongo ML; San Diego Unified Practice Research in Family Medicine Network. The use of complementary and alternative medicine by primary care patients. A SURF*NET Study. J Fam Pract 2000;49:1121-1130.

  5. Simon L, Prebay D, Beretz A, Bagot JL, Lobstein A, Rubinstein I, et al. Complementary and alternative medicines taken by cancer patients. Bull Cancer 2007;94:483-488.

  6. Artus M, Croft P, Lewis M. The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain. BMC Fam Pract 2007;8:26.

  7. García-Planella E, Marín L, Domènech E, Bernal I, Mañosa M, Zabana Y, et al. Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease. Med Clin 2007; 128:45-48.

  8. Gómez-Martínez R, Tlacuilo-Parra A, Garibaldi- Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental, Mexico. Pediatr Blood Cancer 2007;49: 820-823.

  9. Carmona-Sánchez R, Tostado-Fernández FA. Prevalence of use of alternative and complemen-tary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. Rev Gastroenterol Mex 2005;70: 393 -398.

  10. Dole EJ, Rhyne RL, Zeilmann CA, Skipper BJ, McCabe ML, Dog TL. The influence of ethnicity on use of herbal remedies in elderly Hispanics and non-Hispanic whites. J Am Pharm Assoc 2000;40: 349-351.

  11. Harnack LJ, Rydell SA, Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 2001; 76:688-694.

  12. Taddei-Bringas GA, Santillana-Macedo MA, Romero- Cancino JA, Romero-Téllez MB. Acceptance and use of medicinal plants in family medicine. Salud Publica Mex 1999;41:216-220.

  13. Sparber A, Wootton JC, Bauer L, Curt G, Eisenberg D, Levin T, et al. Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J Altern Complement Med 2000;6:415-422.

  14. Standish LJ, Greene KB, Bain S, Reeves C, Sanders F, Wines RC, et al. Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care 2001;13:197-208.

  15. Colebunders R, Dreezen C, Florence E, Pelgrom Y, Schrooten W; Eurosupport Study Group. The use of complementary and alternative medicine by persons with HIV infection in Europe. Int J STD AIDS 2003;14:672-674.

  16. Brauchli P, Reuteler I, Bürki B, Saller R. Use of complimentary medical therapies in HIV/AIDS in Switzerland. Schweiz Med Wochenschr 1996;126: 1297-1305.

  17. Power R, Gore-Felton C, Vosvick M, Israelski DM, Spiegel D. HIV: effectiveness of complementary and alternative medicine. Primary Care 2002;29: 361-378.

  18. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John’s wort. Lancet 2000;355:547-548.

  19. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 2000; 14:333-338.

  20. Hasan MY, Das M, Behjat S. Alternative medicine and the medical profession: views of medical students and general practitioners. East Mediterr Health J 2000;6:25-33.

  21. Chez RA, Jonas WB, Crawford C. A survey of medical students’ opinions about complementary and alternative medicine. Am J Obstet Gynecol 2001;185:754-757.

  22. Carlston M, Stuart MR, Jonas W. Alternative medicine instruction in medical schools and family practice residency programs. Fam Med 1997;29: 559-562.

  23. Jonas W. Alternative medicine and the conventional practitioner. JAMA 1998;279: 708-709.

  24. Conasida. Datos al 30 de junio del 2008. Disponible en http://www.salud.gob.mx/conasida/estadis/ 2008/panoepide30jun2008.pdf

  25. Sierra-Madero JG. Atención de la persona infectada por VIH. Salud Publica Mex 1995;37:520-523.

  26. Magis-Rodríguez C, Esquivel-Pedraza L, López- Martínez C. Experience in the management of the HIV patient among the physicians of the Secretaría de Salud. Salud Publica Mex 1999;41: 460-465.

  27. Daniel WW. Bioestadística. Bases para el análisis de las ciencias de la salud. Tercera edición. México: Limusa; 1994. p. 202-204.

  28. Romero-Cerecero O, Reyes-Morales H, Herrera- Arellano A, Lozoya-Legorreta X, Tortoriello-García J. Aceptación de los fitofármacos por médicos y pacientes en clínica de atención primaria en México. Rev Med IMSS 2004;42(2):125-130.

  29. Hernández-Ávila M, Garrido F, Salazar-Martínez E. Sesgos en estudios epidemiológicos. Salud Publica Mex 2000;42:438-446.

  30. Groom SN, Johns T, Oldfield PR. The potency of immunomodulatory herbs may be primarily dependent upon macrophage activation. J Med Food 2007;10:73-79.

  31. Cahuana-Vasquez RA, Santos SS, Koga-Ito CY, Jorge AO. Antimicrobial activity of Uncaria tomentosa against oral human pathogens. Braz Oral Res 2007;21:46-50.

  32. Ponce-Macotela M, Rufino-González Y, de la Morade la Mora JI, González-Maciel A, Reynoso-Robles R, Martínez-Gordillo MN. Mortality and morphological changes in Giardia duodenalis induced by exposure to ethanolic extracts of Justicia spicigera. Proc West Pharmacol Soc 2001; 44:151-152.

  33. Meckes M, David-Rivera AD, Nava-Aguilar V, Jiménez A. Activity of some Mexican medicinal plant extracts on carrageenan-induced rat paw edema. Phytomedicine 2004;11:446-451.

  34. Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, et al. An in vitro evaluation of human cytochrome P450 3A4 and Pglycoprotein inhibition by garlic. J Pharm Pharm Sci 2001;4:176-184.

  35. Culm-Merdek KE, von Moltke LL, Gan L, Horan KA, Reynolds R, Harmatz JS, et al. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir. Clin Pharmacol Ther 2006; 79:243-254.

  36. Endres HG, Molsberger A, Lungenhausen M, Trampisch HJ. An internal standard for verifying the accuracy of serious adverse event reporting: the example of an acupuncture study of 190 924 patients. Eur J Med Res 2004;9:545-551.

  37. Klougart N, Leboeuf-Yde C, Rasmussen LR. Safety in chiropractic practice. Part I. The occurrence of cerebrovascular accidents after manipulation to the neck in Denmark from 1978-1988. J Manipulative Physiol Ther 1996;19:371-377.

  38. Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003;162: 72-80.

  39. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997;157: 913-919.

  40. Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutr 2000;3:111.

  41. Gamundi R, Valdivia M. The Kombucha mushroom: two different opinions. Sidahora 1995;34-35.

  42. Ciganda C, Laborde A. Herbal infusions used for induced abortion. J Toxicol Clin Toxicol 2003;41: 235-239.

  43. Wynia MK, Eisenberg DM, Wilson IB. Physicianpatient communication about complementary and alternative medical therapies: a survey of physicians caring for patients with human immunodeficiency virus infection. J Altern Complement Med 1999;5: 447-456.

  44. Saw JT, Bahari MB, Ang HH, Lim YH. Potential drug-herb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 2006;12:236- 241.

  45. Moss AR, Bacchetti P, Osmond D, Dritz S, Abrams D, Conant M, et al. Incidence of the acquired immunodeficiency syndrome in San Francisco, 1980- 1983. J Infect Dis 1985;152:152-161.




2020     |     www.medigraphic.com